BACKGROUND: African Americans with head and neck squamous cell carcinoma (HNSCC) have a lower survival rate than whites. This study investigated the functional importance of ancestry-informative single-nucleotide polymorphisms (SNPs) in HNSCC and also examined the effect of functionally important genetic elements on racial disparities in HNSCC survival. METHODS: Ancestry-informative SNPs, RNA sequencing, methylation, and copy number variation data for 316 oral cavity and laryngeal cancer patients were analyzed across 178 DNA repair genes. The results of expression quantitative trait locus (eQTL) analyses were also replicated with a Gene Expression Omnibus (GEO) data set. The effects of eQTLs on overall survival (OS) and disease-free survival (DFS) were evaluated. RESULTS: Five ancestry-related SNPs were identified as cis-eQTLs in the DNA polymerase b (POLB) gene (false discovery rate [FDR] < 0.01). The homozygous/heterozygous genotypes containing the African allele showed higher POLB expression than the homozygous white allele genotype (P <.001). A replication study using a GEO data set validated all 5 eQTLs and also showed a statistically significant difference in POLB expression based on genetic ancestry (P 5.002). An association was observed between these eQTLs and OS (P <.037; FDR < 0.0363) as well as DFS (P 5.018 to .0629; FDR < 0.079) for oral cavity and laryngeal cancer patients treated with platinum-based chemotherapy and/or radiotherapy. Genotypes containing the African allele were associated with poor OS/DFS in comparison with homozygous genotypes harboring the white allele. CONCLUSIONS: Analyses show that ancestry-related alleles could act as eQTLs in HNSCC and support the association of ancestry-related genetic factors with survival disparities in patients diagnosed with oral cavity and laryngeal cancer. Cancer 2017;123:849-60.
INTRODUCTION
African Americans (AFR-AMRs) with head and neck squamous cell carcinoma (HNSCC) have consistently lower survival rates in comparison with white patients. 1, 2 Previous studies have associated socioeconomic status with these survival differences. 3 However, recent literature suggests the contribution of genetic differences between populations to survival disparities in some cancer types. 4 Survival from cancer depends on the success of common treatment methods such as chemotherapy, radiotherapy, and surgery. Treatment planning for potentially curable disease often requires a multidisciplinary approach. [5] [6] [7] Ionizing radiation generates free radicals, which damage cellular DNA; this results in apoptosis. 8 In chemotherapy, platinum-based drugs such as cisplatin and carboplatin are commonly used to treat HNSCC. 9, 10 These platinum-based drugs bind to DNA and form DNA adducts, 11 and this leads to cell cycle arrest and cytotoxicity. 12 In response to DNA lesions caused by chemotherapy and/or radiotherapy, the cellular DNA damage response system repairs DNA aberrations and can reduce treatment sensitivity in cancer patients. 13, 14 Thus, DNA repair genes play a key role in the treatment outcomes for many cancers, including HNSCC.
Higher level expression of DNA repair genes have been observed in many cancer types, 15, 16 and increased expression levels of DNA repair genes are associated with reduced sensitivity to chemotherapy and radiation therapy. 17, 18 The increased expression of DNA repair genes in some cancers arises from multiple factors, including signaling within the tumor or from the tumor microenvironment, which leads to epigenetic upregulation, and/or de novo somatic mutations. Some evidence suggests that host genomic factors such as germline variants in DNA repair-associated genes may be associated with individual differences in responses. Previous studies have shown that germline variants can act as expression quantitative trait loci (eQTLs) and affect the expression of genes in cancer. 19 Such germline variants may be preferentially found in certain populations. Indeed, a number of studies have investigated the effect of population-specific genetic variants on gene expression in normal, non-cancer samples from various human populations and identified differential gene expression levels regulated by ancestry-related alleles. 20 AFR-AMR and white HNSCC patients possess distinct genetic ancestries. Our recent genomic analysis of laryngeal cancer in AFR-AMR and white patients revealed that distinctive genetic ancestry corresponds to molecular differences in the laryngeal cancers arising in these 2 populations. 21 To date, the functional role of populationspecific genomics variants in HNSCC survival is unknown. In this study, the functional role of ancestryrelated genomic factors in the expression of DNA damage response genes and the effect of ancestry-informative single-nucleotide polymorphisms (SNPs) on racial disparities in HNSCC survival were investigated with an integrative genomics approach. We tested the hypothesis that ancestry-related genomic elements are associated with HNSCC survival disparities between AFR-AMR and white populations because of altered gene expression in DNA damage response genes, which affects the sensitivity to chemotherapy and/or radiotherapy. This work, focusing on oral cavity and laryngeal cancer, is the first study to investigate the functional importance of ancestryinformative SNPs in HNSCC and to examine the effect of functionally important genetic elements on racial disparities in HNSCC survival.
MATERIALS AND METHODS

Data Source
The genotype data for 4802 genome-wide ancestry-informative SNPs for 316 oral cavity and laryngeal cancer patients (30 AFR-AMRs and 286 whites) were retrieved from The Cancer Genome Atlas (TCGA) for eQTL analyses. Detailed methodologies explaining how the 4802 ancestry-informative SNPs were retrieved from TCGA are provided in the online supporting information. The raw genome-wide methylation data for approximately 485,000 CpG sites, based on the Infinium HumanMethylation450 BeadChip Kit (Illumina, Inc), were retrieved for the tumors of the 316 HNSCC patients from TCGA. The M values (methylation signals) were calculated for each CpG site with the Bioconductor minfi package. 22 The somatic copy number variation (CNV) data and RNA sequencing-based gene expression data (normalized RSEM values) for the tumors of the 316 HNSCC patients in TCGA were also obtained from the Broad Institute.
23
A gene was included in the analyses only when 50% or more of the patients had expression values for that gene.
eQTL Analyses
The effect of each ancestry-informative SNP on the expression of nearby genes (61 Mb from the SNP) was analyzed to find potential ancestry-related eQTL candidates. A multivariable regression model was used to identify eQTLs (equation 1). A negative binomial regression model, based on the empirical mean-variance relation for gene expression, was used:
where Exp a is the expression of gene a, GT a is the genotype of the single-nucleotide polymorphism under study, CNV a is the somatic copy number variation of gene a, M a indicates the methylation levels of CpG sites associated with gene a, Pop a indicates the top 3 principal component values to adjust for population stratification, and e a is the residual error.
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The regression analyses were performed with the MASS package in R (version 3.0.2). All tests were 2-sided, and P values were corrected for multiple tests according to the Benjamini-Hochberg method (false discovery rate [FDR] ). Potential ancestry-informative SNPs affecting the expression of DNA repair genes with an FDR 0.01 were retrieved. A list of 178 DNA repair genes (updated on April 15, 2014) was obtained from the online resource of The University of Texas MD Anderson Cancer Center 24 for our study. This comprehensive set of DNA repair genes has been used widely in several recent publications. 25, 26 We also tested the effects of eQTLs (found in the pooled data set [30 AFR-AMRs and 286 whites]) on the expression of DNA repair genes with the regression model (equation 1) using the data set for white patients (n 5 286).
Other Statistical Analyses
Age distribution differences between AFR-AMR and white patients were studied with the Mann-WhitneyWilcoxon test. Differences in the proportions of current smokers, ex-smokers, and never smokers, and each pathological stage between AFR-AMR and white patients were assessed with a test of proportions. Gene expression levels of AFR-AMR and white patients were compared with the Mann-Whitney-Wilcoxon test. The genotype data were retrieved for each eQTL on the basis of ancestry, and the allele frequencies of each eQTL were calculated. Also, the allele frequencies of each eQTL were retrieved for ASW (African ancestry in the Southwest United States) and CEU (Utah residents with Northern and Western European ancestry) populations from 1000 Genomes Project (1000G) data, and the proportions of allele frequencies were compared between TCGA and 1000G samples (ASW vs TCGA AFR-AMRs and CEU vs TCGA whites) with a test of proportions. All tests were 2-sided, and P values .05 were considered to be statistically significant.
Replication of eQTL Analyses
The TCGA eQTL analyses were replicated with a Gene Expression Omnibus (GEO) data set (GSE39368) generated by Walter et al. 27 This data set contains genomewide SNP and CNV data for 99 HNSCC patients and gene expression data for 138 HNSCC patients. The SNP, CNV, and gene expression data sets were combined into a single data set with missing values coded as Not Available (NA). Data were extracted if a patient's ancestry was either AFR-AMR or white and the anatomical site represented the oral cavity or larynx. After these filters, data for 96 HNSCC patients (73 whites and 23 AFR-AMRs) were retrieved for further analyses. In this data set, the expression of each gene was measured with multiple probes, and the mean of multiple probes of each gene was taken as the expression measure of that gene. The effect of each SNP identified as an eQTL in the TCGA data set on gene expression was tested with the linear regression model after adjustments for CNV.
Linkage Disequilibrium (LD) Analyses
Genomic data for all the eQTLs and SNPs within a distance of 650 kb from each eQTL were retrieved for the ASW population from the 1000G database, and LDs between each eQTL and its nearby SNPs were analyzed with VCFtools. 28 SNPs in strong LD (scaled linkage disequilibrium estimate [D 0 ] 0.8) with eQTLs were identified for further analyses. The LD heat map was generated with Haploview software. 29 
Encyclopedia of DNA Elements (ENCODE) Functional Analyses
The genome-wide deoxyribonuclease (DNase) I sensitivity assay data and transcription factor binding sites were retrieved from ENCODE. 30 Each eQTL and LD SNP was intersected with the ENCODE database with custom Perl and Shell scripts. The eQTL/LD SNP was thought to be functionally important if the eQTL/SNP was found in the regulatory region of a gene, and DNase I sensitivity and/or transcription factor binding site. The genomic position of functionally important eQTL/SNPs was visualized with the University of California Santa Cruz genome browser. 31 
Survival Analyses Based on eQTLs
The effect of eQTLs on overall survival (OS) and diseasefree survival (DFS) for HNSCC patients with a history of platinum-based chemotherapy and/or radiation therapy was investigated. First, Kaplan-Meier plots were generated for each eQTL to visualize the effect of eQTL genotypes with Stata (version 14.01). Second, hazard ratios (HRs) for the risk of death (OS) according to the eQTL genotype were calculated with Cox proportional hazards regression models after adjustments for age and pathological stage with the survival package in R, and a goodness-of-fit test using Schoenfeld residuals was performed to test the appropriateness of the Cox proportional hazards model. 32 All tests were 2-sided, and a P-value threshold of .05 was used to determine statistical significance. The P values were corrected for multiple tests with the BenjaminiHochberg method.
To validate the survival analyses results, existing germline DNA and clinical data for 20 additional oral cavity or laryngeal cancer patients of African (AFR) ancestry who had platinum-based chemotherapy and/or radiation therapy were obtained. 33 Germline DNA for all 20 patients was genotyped for 1 of the eQTLs (rs2272733) with a TaqMan real-time polymerase chain reaction assay (Life Technologies/Thermo Fisher Scientific, Waltham, Mass). The genotype and clinical data for these 20 patients were combined with the data for 157 patients from TCGA to generate an enriched data set (data set 2) containing 177 HNSCC patients (36 AFR-AMR patients and 141 white patients) with a history of platinum-based chemotherapy and/or radiation therapy for survival analyses. All the human subject investigations were approved by institutional review boards of the Fox Chase Cancer Center.
Estimation of Admixture Proportions and Survival Analyses
Autosomal ancestry-informative marker data for TCGA patients along with YRI (Yoruba African), CEU, JPT (Japanese Tokyo), and CHB (Han Chinese) individuals from 1000G were retrieved. The genetic admixture proportions for each individual, including AFR-AMR and white patients from TCGA, were estimated with a modelbased clustering approach implemented in STRUC-TURE (version 2.3.4). 34 In STRUCTURE, the data were analyzed with different K values (genetic clusters) ranging from 3 to 10 under the admixture model. For each K value, 10 runs were performed with 10,000 burn-in and an additional 20,000 replicates. The best K value was estimated with the method of Evanno et al 35 as implemented in the STRUCTURE HARVESTER program. 36 The output of STRUCTURE based on the best K value was analyzed with CLUMPP. 37 The AFR-admixed fraction of each HNSCC patient (n 5 157) with platinum-based chemotherapy and/or radiotherapy history was obtained from the CLUMPP output and used for survival analyses. The effects of the AFR-admixed proportion on OS and DFS were analyzed with Cox proportional hazards regression models from the survival package in R after adjustments for age and pathological stage. Goodness-of-fit tests using Schoenfeld residuals were performed to evaluate the appropriateness of the Cox proportional hazards model. All tests were 2-sided, and a P-value threshold of .05 was used to determine statistical significance.
RESULTS
TCGA Sample Characteristics
Summary statistics for the 316 HNSCC patients included in this analysis are provided in Table 1 . The differences in age, smoking status, and pathological stage between AFR-AMR and white patients were not significant.
Effect of Ancestry-Informative SNPs on the Expression of DNA Repair Genes (eQTL Analysis)
The focus of this study was an analysis of the effect of ancestry-informative SNPs on an annotated set of 178 DNA repair genes. Our results showed that the expression of 1 DNA repair gene, DNA polymerase b (POLB), was significantly affected by nearby ancestry-informative SNPs with an FDR 0.01. Among 4802 ancestryinformative SNPs, 5 SNPs (rs2272733, rs3136790, rs6474387, rs2272732, and rs10096210) were found to be eQTLs affecting the expression of POLB (FDR 0.01). Each of the 5 SNPs was also observed to be an eQTL when the data set was limited to whites only. The P values for the 5 SNPs based on pooled (AFR-AMR and white) and white data sets are reported in Supporting Table 1 (see online supporting information). As an illustration, the effects of rs2272732 on POLB are shown in Figure 1 (TCGA panel). The effects of the other 4 SNPs on POLB were similar to the effects of rs2272732 (Supporting Fig. 1 [see online supporting information] ). In this article, we use the terms AFR allele and white allele to Original Article denote the major alleles specific to AFR-AMR and white populations, respectively. Homozygous genotypes containing the AFR allele were associated with higher levels of POLB, whereas homozygous white-allele genotypes had decreased POLB expression. Heterozygous genotypes containing an AFR allele and a white allele were associated with moderately higher levels of POLB expression (TCGA panel in Fig. 1B There was a statistically significant difference in POLB expression between AFR-AMR and white patients (P < .001; TCGA panel in Fig. 1C ).
Replication of eQTL Analyses
The results of eQTL analyses based on TCGA data were replicated with a GEO data set and were consistent with the results observed from the TCGA data analyses. The regression analyses identified all 5 SNPs as eQTLs affecting the expression of the POLB gene (P < .007). The effects of rs2272732 on POLB expression in the GEO data set are shown in Figure 1 (GEO panel). As with the TCGA data, homozygous AFR-allele genotypes of all 5 SNPs were associated with higher expression levels of POLB in comparison with the homozygous white-allele genotype from the GEO data set. Also, the heterozygous genotypes had moderately higher levels of POLB expression than the homozygous genotypes of the white allele. An evaluation of GEO data confirmed that AFR-AMR patients had a higher level of POLB expression (Q1, -0.10; median, 0.07; Q3, 0.35) than white patients (Q1, -0.61; median, -0.26; Q3, 0.09), and there was a significant difference in POLB expression levels between the 2 populations (P 5 .002).
LD and ENCODE Analyses
The results of the LD analyses are shown in Figure 2 . Each of the 5 eQTLs was in strong LD (D 0 0.9) with the others. In addition, another ancestry-informative SNP, rs3136717, had a strong association with all 5 eQTLs (D 0 > 0.8). The functional importance of the 5 eQTLs and rs3136717 was investigated with the EN-CODE data. None of the 5 eQTLs were found to be in the POLB gene region with strong DNase I sensitivity/TF binding signals. However, the associated ancestryinformative SNP, rs3136717, was located in the regulatory region of POLB and in the DNase I sensitivity region of POLB in all 125 cell lines assayed in the ENCODE project. In addition, rs3136717 is located in the binding site of several transcription factors, specifically polymerase (RNA) II subunit A (POLR2A). The genomic position and associated ENCODE annotations for rs3136717 are shown in Figure 3 .
Allele Frequencies of eQTLs Between TCGA and 1000G Data
The allele frequencies of the 5 eQTLs for AFR-AMR and white patients in TCGA were estimated and compared with the allele frequencies of their respective populations (ASW for AFR-AMR patients [ Figure 4A ] and CEU for white patients [ Figure 4B ]) from the 1000G data. The allele frequencies from the TCGA and 1000G data sets were not significantly different.
Survival Analyses Based on eQTLs
The effect of each eQTL on the OS of HNSCC patients who were treated with platinum-based chemotherapy and/or radiotherapy (n 5 157; 16 AFR-AMRs and 141 whites) was examined. All 5 eQTLs were found to be significantly associated with OS (log-rank test P < .037; FDR < 0.0363). The Kaplan-Meier plot for a representative eQTL, rs2272733, is shown in Figure 5A . The Kaplan-Meier plots for the other 4 eQTLs are shown in Supporting Figure 2 (see online supporting information). The DFS analyses found that rs2272732 and rs2272733 were significantly associated with DFS (P < .05), whereas rs3136790 and rs10096210 were associated with DFS with moderate significance (P 5 .0544 to .0629). The Kaplan-Meier plots of DFS for each of the 5 eQTLs are shown in Supporting Figure 3 (see online supporting information). The OS HRs for each genotype of the 5 eQTLs were calculated with the Cox proportional hazards model after adjustments for age and pathological stage ( Table 2 ). The goodness-of-fit test confirmed the appropriateness of the Cox proportional hazards model for OS analyses. For 4 of the 5 eQTLs, patients with the homozygous genotype of the white allele had a significantly lower risk of death (P < .0003; FDR < 0.0008) than patients with the homozygous AFR allele. Also, patients with the heterozygous genotypes for rs2272733 and rs3136790 were found to have a significantly lower risk of death (P < .002; FDR < 0.0016) than patients who had homozygous genotypes consisting of the AFR-AMR major allele. The HR for the genotypes of rs6474387 was not found to be significant.
We also evaluated the effect of the 5 eQTLs on the OS and DFS of patients not treated with cisplatin/carboplatin/radiotherapy. None of the eQTL genotypes were found to be significantly associated with OS (P > .6) or DFS (P > .8).
Validation of eQTL-Based Survival Analyses
The survival analysis results from data set 2 for SNP rs2272733 were consistent with the results for rs2272733 from the TCGA data set. The Kaplan-Meier plot and survival rates are shown in Figure 5B . The homozygous genotype of the AFR allele (AA) was associated with lower OS in comparison with the other 2 genotypes (AG and GG; log-rank test P 5 .056). The Cox proportional hazards model, after adjustments for age, clinical stage, and cohort, revealed that patients with heterozygous genotype AG had a significantly lower risk of death than patients with homozygous AFR allele genotype AA (HR for AA vs AG, 0.26; 95% confidence interval [CI], 0.08-0.84; P 5 .024). Also, patients with the homozygous genotype containing the white allele (GG) had a significantly lower risk of death than patients with the homozygous AFR-AMR genotype (AA; HR for AA vs GG, 0.15; 95% CI, 0.04-0.48; P 5 .0012).
Survival Analyses Based on Genetic Proportions
The main objective of this article was to understand the effect of AFR ancestry on survival disparities in HNSCC. Thus, we analyzed the effect of AFR admixture on survival in HNSCC patients with a history of platinum-based chemotherapy and/or radiotherapy. The HRs for OS and DFS were 8.99 (95% CI, 1.53-52.95; P 5 .015) and 7.12 (95% CI, 1.46-34.77; P 5 .015), respectively. The goodness-of-fit test confirmed the appropriateness of the Cox proportional hazards model for OS and DFS analyses.
DISCUSSION
Ancestry-Informative SNPs Act as eQTLs
Our stringent criteria (FDR0.01) found 5 ancestryinformative SNPs to be eQTLs affecting POLB expression. This is the first study to demonstrate the impact of ancestry-informative SNPs on the expression of a gene involved in head and neck cancer tissues with a subsequent effect on survival disparities. The expression level of POLB significantly differed between AFR-AMR and white patients (P < .001), with AFR-AMR patients possessing higher levels of POLB expression in their tumors than white patients because of ancestry-related eQTLs. In general, major factors that could alter gene expression are SNPs (eQTLs), CNVs, somatic point mutations, methylation, and population differences. In our analyses, we included CNV, methylation, and the top 3 principal components in our regression model. Therefore, the effects of CNV, methylation, and population structure on POLB expression were adjusted, and this suggests an independent association of SNPs with gene expression. In addition, our candidate SNPs were also found to be eQTLs when they were tested exclusively with a white patient data set. We also checked somatic point mutations in our TCGA cohort based on exome data and did not find any somatic point mutations in the POLB gene.
The allele frequencies of the 5 eQTLs for AFR-AMR patients and the 1000G ASW population and for white patients and the 1000G CEU population were not significantly different ( Fig. 2 ; P > .6). Thus, we expect to observe the same effect for these eQTLs that we found in TCGA patients in any AFR-AMR and white populations. However, the effects of eQTLs in AFR-AMR and white controls (non-cancer samples) remain to be determined. Figure 4 reveals that candidate eQTL allele frequencies were different between AFR-AMR and white individuals, regardless of which data set (TCGA or 1000G) was used. In addition, for all 5 eQTLs, each specific allele was enriched in AFR-AMR patients versus white patients.
We also validated the results of the TCGA data set by replicating the eQTL analyses with a GEO data set. If the results obtained from the TCGA data set occurred by chance or were due to some unknown factors associated with TCGA samples, we would expect to see different results with the GEO data set. Indeed, the results for the 5 ancestry-informative SNPs based on the GEO data set were consistent with the results of TCGA data analyses. Each of the 5 eQTLs observed in the TCGA data were identified as eQTLs and affected POLB expression in the GEO data set (Fig. 1) . Thus, we provide evidence that ancestry-informative SNPs could act as eQTLs and alter the expression of genes in HNSCC. Although these results were observed on the basis of RNA expression, further study is required to confirm the effect of eQTLs on protein expression.
Increased levels of POLB expression have been shown to be associated with tumorigenesis. 38, 39 In addition, an increased level of POLB expression has been observed in many cancer types, 40 and this suggests that a higher level of POLB expression could be associated with the risk of HNSCC. Compared with other groups, AFRAMRs have a higher incidence of HNSCC, particularly in the larynx. These observations support the association between HNSCC incidence disparities and ancestryinformative SNPs. However, further studies are needed to confirm this association.
Identification of Potentially Functionally Important eQTLs
All 5 eQTLs are located within or near ( 6 1Mb) the POLB gene region, and all 5 eQTLs are in strong LD. In addition, we have identified another ancestry-informative SNP, rs3136717, for which data are not available in TCGA and GEO data sets, in strong LD with the 5 eQTLs. It is expected that rs3136717 will be associated with levels of POLB expression similar to those observed with the other 5 eQTLs. Unfortunately, we could not test the effect of rs3136717 on POLB because of the unavailability of genotype data for rs3136717 in TCGA. Our analyses have shown that rs3136717 is found at the 5 0 end of the POLB gene and in the DNase I sensitivity region in all 125 surveyed cell lines. In addition, rs3136717 is located in the region where the transcription factor POLR2A binds to the POLB gene (Fig. 4) . Thus, rs3136717 is likely in an active regulatory region of the POLB gene. POLR2A is the major subunit of RNA polymerase II, which is required for RNA transcription. Because rs3136717 is in an active regulatory region and on the POLR2A binding site, we speculate that alternative alleles of rs3136717 could affect the binding affinity of POLR2A or other transcription factors to alter POLB gene expression. It is interesting to note that Figueroa el al 41 have already identified rs3136717 as being associated with the risk of bladder cancer in a case-control study.
Thus, rs3136717 could be functionally important and could be associated with the risk of many cancers, including HNSCC. The role of rs3136717 in POLB expression in HNSCC needs to be further evaluated experimentally.
Effect of Ancestry-Related Genomic Variants on the Treatment Outcome
Higher levels of POLB expression decrease the sensitivity of platinum-based chemotherapy and/or radiotherapy and thus may be associated with poor survival. 42, 43 Therefore, the 5 eQTLs shown to modulate POLB expression are expected to affect the outcomes of patients treated with platinum-based chemotherapy and/or radiation therapy. Among patients treated with platinum-based drugs and/or radiotherapy, the genotypes of eQTLs containing the AFR allele (homozygous/heterozygous) were associated with poor OS and DFS in comparison with the homozygous genotypes containing the white allele. Even after adjustments for age and pathological stage, statistically significant associations persisted. However, the results of OS analyses were slightly different among eQTLs (Table  2) , even though these eQTLs were in strong LD. In addition, the effect of these eQTLs on DFS differed among eQTLs. This is not surprising because it is known that independent cis-eQTLs in LD can have different functional effects. 44 We also studied the effect of eQTLs among patients who were not treated with cisplatin/carboplatin/ radiotherapy, and the results did not show any significant effect of eQTLs on the OS (P > .6) or DFS of these patients (P > .8). These findings provide evidence showing that the associations of these 5 eQTLs with OS/DFS were limited to patients with a cisplatin/carboplatin/radiotherapy treatment history and support the important role that POLB expression plays in treatment response.
We validated our survival analyses by analyzing 1 of the 5 eQTLs, rs2272733, in 141 white HNSCC patients and 36 HNSCC patients of AFR ancestry with a history of platinum-based chemotherapy and/or radiation therapy (data set 2). The results of TCGA and data set 2 for rs2272733 were consistent. The genotype containing at least 1 AFR allele (A) was associated with poorer OS in comparison with the homozygous white-allele (G) genotype.
To further test the idea that an AFR genetic ancestry is indeed related to survival disparities, we assayed the effect of AFR-admixed proportions on OS and DFS. The HRs for OS and DFS were >1.0, and this indicates that a higher AFR admixture is associated with poorer OS and DFS in HNSCC patients with a platinum-based chemotherapy and/or radiotherapy history. These results are Original Article statistically significant; however, it is worth noting the wide CIs, which are partly due to the limited amount of data available for these endpoints. Moreover, a similar analysis using data from the entire cohort of subjects in this study showed similar tendencies and indicated poorer OS and DFS in patients with increasing AFR genetic admixture (data not shown). Thus, our study reveals a clear association between AFR ancestry-related genetic factors and poor treatment outcomes in AFR-AMR patients with HNSCC who were treated with platinum-based chemotherapy and/or radiotherapy. The validation of our findings in a larger independent cohort of subjects would help to further strengthen and establish their significance.
A limitation of this study is that socioeconomic status and environmental factors were not included in the analyses because such data were not available. However, we cannot ignore the effects of environmental factors and socioeconomic status on survival disparities. Thus, this study needs to be extended further to analyze the interactions between genetics and environmental factors/socioeconomic status with respect to survival disparities. 
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